Do you want to read an article? Please log in or register.
Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Related content
COMMENTED
Heart, Artery and Coronary Diseases
Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med
Lee YJ, Lee SJ, Kim JW, Lee SH, Kim GS, Park JH, Cho JM, Kang WC, Yoon HJ, Kim WH, Lee SJ, Lee JB, Jang JY, Shin S, Park IH, Kwon SU, Kim S, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, Kim BK, Ez-PAVE Investigators
doi: 10.1056/NEJMoa2600283
Heart, Artery and Coronary Diseases
Persistent gaps in management and risk factor control among patients with atherosclerotic cardiovascular disease: All of us research program
Atherosclerosis
Bene-Alhasan Y, Al Osta S, Issaka Y, Acquah I, Alkhatib A, Othman L, Mensah SO, Howard A, Ballantyne CM, Virani SS, Nambi V, Osei AD
doi: 10.1016/j.atherosclerosis.2026.120794
Further Publications
Unsupervised Learning Analysis of Triglycerides, Inflammation, Cholesterol, and the Risks of Incident Cardiovascular Disease and Type 2 Diabetes in the Women's Health Study
J Am Heart Assoc
Duran EK, Cook NR, Aday AW, Buring JE, Ridker PM, Pradhan AD
doi: 10.1161/JAHA.123.039381
Cardiovascular Risk and DiseasesHeart Failure
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model
Eur Heart J
Reitsma TH, Lim CE, Gynnild MN, Kaptoge S, Lõo L, Holtrop J, Kuźma Ł, Pennells L, Conrad N, Ueda P, Jernberg T, Kurasz A, Keene SJ, Chilala C, Deo SV, Tillmann T, Khunti K, Piepoli M, Rossello X, Savarese G, Dalen H, Steg PG, Wood AM, Lees JS, Kavousi M, McEvoy JW, de Boer RA, Andersson C, Bhatt DL, Visseren FLJ, Dorresteijn JAN, Koudstaal S, Di Angelantonio E, Hageman SHJ, UCC-SMART study group, ESC Cardiovascular Risk Collaboration
doi: 10.1093/eurheartj/ehag153
Cardiovascular Risk and Diseases
Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Atherosclerosis
Tscharre M, Mutschlechner D, Huber K, Gremmel T
doi: 10.1016/j.atherosclerosis.2025.120478
Cardiovascular Risk and Diseases
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial
JAMA Cardiol
Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK, Mandavya K, Davicevic-Elez Z, Jeppesen OK, Lorenzatti A, Oguz A, Mankovsky B, Deerochanawong C, Gorgojo-Martinez JJ, Ji L, Bain SC, McGuire DK, Buse JB, SOUL Study Group
doi: 10.1001/jamacardio.2026.0245
RECOMMENDED
Cardiovascular Risk and DiseasesFurther Publications
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Nordestgaard AT, Chasman DI, Moorthy V, Kraaijenhof JM, Cook NR, Lee IM, Buring JE, Ridker PM
doi: 10.1001/jamacardio.2025.5043
COMMENTED
Further Publications
Cardiovascular Risk and Eye Health: A Prospective Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmology
Sun D, Tseng VL, Yu F, Coleman AL
doi: 10.1016/j.ophtha.2025.12.021
Cardiovascular Risk and Diseases
Maternal Diabetes and Risk of Early-Onset Cardiovascular Diseases in Offspring
JAMA Cardiol
Mo X, Janszky I, Wang H, Yang F, Möller J, Liang Y, László KD
doi: 10.1001/jamacardio.2026.0915